C5447355_NCI_FDA | Knowledge4COVID-19

Property	Value
?:definition	Used in ophthalmic preparations to enhance the retention of active ingredients by reducing the amount of product that is lost from the eye when the patient blinks. In addition, polymers also can be components of artificial tears. (Adapted from USP <1059>)
?:hasCUIAnnotation	<https://research.tib.eu/covid-19/entity/C5447355>
?:hasGeneratedBy	<https://research.tib.eu/covid-19/SourceName/NCI_FDA>
?:type	<https://research.tib.eu/covid-19/vocab/AnnotationDefinition>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C5447355_NCI_FDA>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C5447355_NCI_FDA>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all